Literature DB >> 299768

Characterization of self-reactive B cells by polyclonal B-cell activators.

D Primi, L Hammarström, C I Smith, G Möller.   

Abstract

The existence of autoreactive B cells was predicted by theoretical considerations and, recently, confirmed by direct experiments. The aim of the present work was to investigate if the capacity of self-reactive B cells to be activated with different polyclonal B-cell activators (PBA) reflects the heterogeneity of the response as seen in all the Ig-positive cells. We injected mice with dextran sulfate, lipopolysaccharide from Escherichia coli 055:B5, and purified protein derivate of turbercle bacteria RT32 and studied the complement-dependent cytotoxicity against syngeneic spleen cells caused by the sera from injected mice with regard to the different parameters used for characterization of B-cell subpopulations. It was found that the capacity of self-reactive B cells to secrete antibodies reflects the polyclonal-activating capacity of the PBA used. The implications of these findings for the understanding of the triggering mechanism of B lymphocytes and for self-nonself discrimination are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 299768      PMCID: PMC2180595          DOI: 10.1084/jem.145.1.21

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

Review 1.  Functional analysis of B cell heterogeneity.

Authors:  E Gronowicz; A Coutinho
Journal:  Transplant Rev       Date:  1975

2.  Selective triggering of B cell subpopulations by mitogens.

Authors:  E Gronowicz; A Coutinho
Journal:  Eur J Immunol       Date:  1974-11       Impact factor: 5.532

3.  Differentiation of B cells: sequential appearance of responsiveness to polyclonal activators.

Authors:  E Gronowicz; A Coutinho; G Möller
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

4.  The kinectics of proliferation and maturation of mitogen-activated bone marrow-derived lymphocytes.

Authors:  F Melchers; J Andersson
Journal:  Eur J Immunol       Date:  1974-10       Impact factor: 5.532

5.  In vitro activation of mouse lymphocytes in serum-free medium: effect of T and B cell mitogens on proliferation and antibody synthesis.

Authors:  A Coutinho; G Möller; J Anderson; W W Bullock
Journal:  Eur J Immunol       Date:  1973-05       Impact factor: 5.532

6.  Editorial: Immune activation of B cells: evidence for 'one nonspecific triggering signal' not delivered by the Ig receptors.

Authors:  A Coutinho; G Möller
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

7.  Microplate culture of mouse lymph node cells. I. Quantitation of responses to allogeneic lymphocytes endotoxin and phytomitogens.

Authors:  P E Thorpe; S C Knight
Journal:  J Immunol Methods       Date:  1974-10       Impact factor: 2.303

8.  Improved complementation in the cytotoxic test.

Authors:  E A Boyse; L Hubbard; E Stockert; M E Lamm
Journal:  Transplantation       Date:  1970-11       Impact factor: 4.939

9.  Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen.

Authors:  G Möller; E Gronowicz; U Persson; A Coutinho; E Möller; L Hammarström; E Smith
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

10.  Release of DNA in circulating blood and induction of anti-DNA antibodies after injection of bacterial lipopolysaccharides.

Authors:  G J Fournié; P H Lambert; P A Meischer
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

  10 in total
  23 in total

Review 1.  Membrane Ig-mediated triggering of B cell tolerance and B cell clonal expansion: implications for rheumatoid factor production in rheumatoid synovitis.

Authors:  P K Mongini; S M Rudich
Journal:  Springer Semin Immunopathol       Date:  1989

2.  Evidence for the existence of self-reactive human B lymphocytes.

Authors:  D Primi; C I Smith; L Hammarström; P G Lundquist; G Möller
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

3.  Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease.

Authors:  E C Böttger; T Hoffmann; U Hadding; D Bitter-Suermann
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

4.  Hidden autoantibodies against common serum proteins in murine systemic lupus erythematosus. Detection by in vitro plaque-forming cell assay.

Authors:  P L Cohen; R G Rapoport; R A Eisenberg
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

5.  Glomerular lesions induced in the rabbit by physicochemically altered homologous IgG.

Authors:  F Cavalot; M Miyata; A Vladutiu; V Terranova; S Dubiski; R Burlingame; E Tan; J Brentjens; F Milgrom; G Andres
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

6.  Injection of mouse thyroglobulin and/or adult thymectomy do not break tolerance to thyroglobulin during the lupus like graft versus host disease in mice.

Authors:  F M van Rappard-van der Veen; Y M Kong; N R Rose; M Kimura; E Gleichmann
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

Review 7.  Dysregulation of germinal centres in autoimmune disease.

Authors:  Carola G Vinuesa; Iñaki Sanz; Matthew C Cook
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

8.  Analysis of in vitro polyclonal B cell differentiation responses to bacterial peptidoglycan and pokeweed mitogen in rheumatoid arthritis.

Authors:  I Pardo; C Carafa; R Dziarski; A I Levinson
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

9.  Induction of antibodies directed against self and altered-self determinants by a synthetic adjuvant, muramyl dipeptide and some of its derivatives.

Authors:  I Löwy; C Leclerc; L Chedid
Journal:  Immunology       Date:  1980-03       Impact factor: 7.397

10.  Autoimmune disease and malignant lymphoma associated with host-versus-graft disease in mice.

Authors:  M Tateno; N Kondo; T Itoh; T Yoshiki
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.